Literature DB >> 29202305

Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC-MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD.

Federica Palazzoli1, Cinzia Citti2, Manuela Licata3, Antonietta Vilella4, Letizia Manca4, Michele Zoli4, Maria Angela Vandelli5, Flavio Forni5, Giuseppe Cannazza6.   

Abstract

The investigation of the possible conversion of cannabidiol (CBD) into Δ9-tetrahydrocannabinol (THC) in vivo after oral administration of CBD is reported herein since recent publications suggested a rapid conversion in simulated gastric fluid. To this end, single high dose of CBD (50mg/kg) was administered orally to rats and their blood was collected after 3 and 6h. A highly sensitive and selective LC-MS/MS method was developed and fully validated in compliance with the Scientific Working Group of Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology. This method also involved the optimization of cannabinoids and their metabolites extraction in order to remove co-eluting phospholipids and increase the sensitivity of the MS detection. Neither THC nor its metabolites were detected in rat whole blood after 3 or 6h from CBD administration. After oral administration, the amount of CBD dissolved in olive oil was higher than that absorbed from an ethanolic solution. This could be explained by the protection of lipid excipients towards CBD from acidic gastric juice.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cannabidiol; Cannabinoids extraction; Liquid chromatography; Mass spectrometry; Δ(9)-Tetrahydrocannabinol

Mesh:

Substances:

Year:  2017        PMID: 29202305     DOI: 10.1016/j.jpba.2017.11.054

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  16 in total

1.  Oral Cannabidiol Does Not Convert to Δ8-THC or Δ9-THC in Humans: A Pharmacokinetic Study in Healthy Subjects.

Authors:  José Alexandre S Crippa; Antonio Waldo Zuardi; Jaime Eduardo Cecílio Hallak; Bruna Miyazawa; Sandra Aparecido Bernardo; Carmem Maria Donaduzzi; Silvane Guzzi; Wagner Alex Jann Favreto; Alline Campos; Maria Eugênia C Queiroz; Francisco S Guimarães; Patrícia Moura da Rosa Zimmermann; Letícia Mello Rechia; Volnei Jose Tondo Filho; Liberato Brum Junior
Journal:  Cannabis Cannabinoid Res       Date:  2020-02-27

2.  Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential.

Authors:  Sabrina L Botsford; Sharon Yang; Tony P George
Journal:  Am J Addict       Date:  2019-10-02

3.  Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)-a pilot study.

Authors:  Lanfranco Pellesi; Manuela Licata; Patrizia Verri; Daniele Vandelli; Federica Palazzoli; Filippo Marchesi; Maria Michela Cainazzo; Luigi Alberto Pini; Simona Guerzoni
Journal:  Eur J Clin Pharmacol       Date:  2018-07-06       Impact factor: 2.953

4.  Will tetrahydrocannabinol be formed from cannabidiol in gastric fluid? An in vivo experiment.

Authors:  Simon Franz; Josefine Herzog; Gisela Skopp; Frank Musshoff
Journal:  Int J Legal Med       Date:  2022-10-03       Impact factor: 2.791

5.  Determination of cannabinoids in hemp oil based cosmetic products by LC-tandem MS.

Authors:  Yun-Hua Hsu; Ming-Chih Fang; Shou-Chieh Huang; Ya-Min Kao; Su-Hsiang Tseng; Der-Yuan Wang
Journal:  J Food Drug Anal       Date:  2021-09-15       Impact factor: 6.157

6.  Orally administered cannabidiol does not produce false-positive tests for Δ9 -tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000.

Authors:  Danielle McCartney; Richard C Kevin; Anastasia S Suraev; Christopher Irwin; Ronald R Grunstein; Camilla M Hoyos; Iain S McGregor
Journal:  Drug Test Anal       Date:  2021-08-30       Impact factor: 3.234

Review 7.  The Essential Medicinal Chemistry of Cannabidiol (CBD).

Authors:  Kathryn M Nelson; Jonathan Bisson; Gurpreet Singh; James G Graham; Shao-Nong Chen; J Brent Friesen; Jayme L Dahlin; Matthias Niemitz; Michael A Walters; Guido F Pauli
Journal:  J Med Chem       Date:  2020-09-10       Impact factor: 7.446

8.  Cannabis and Its Permissibility Status.

Authors:  Jawad Alzeer; Khaled Abou Hadeed; Hayriye Basar; Fawzi Al-Razem; Mosaad A Abdel-Wahhab; Yousef Alhamdan
Journal:  Cannabis Cannabinoid Res       Date:  2020-05-12

9.  Origin of Δ9-Tetrahydrocannabinol Impurity in Synthetic Cannabidiol.

Authors:  Cinzia Citti; Fabiana Russo; Pasquale Linciano; Sarah Sylvana Strallhofer; Francesco Tolomeo; Flavio Forni; Maria Angela Vandelli; Giuseppe Gigli; Giuseppe Cannazza
Journal:  Cannabis Cannabinoid Res       Date:  2021-02-12

10.  A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol.

Authors:  Cinzia Citti; Pasquale Linciano; Fabiana Russo; Livio Luongo; Monica Iannotta; Sabatino Maione; Aldo Laganà; Anna Laura Capriotti; Flavio Forni; Maria Angela Vandelli; Giuseppe Gigli; Giuseppe Cannazza
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.